850759C

16:0-20:4 PE

1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine, chloroform

• Synonyme(s) : 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine; PAPE; PE(16:0/20:4(5Z,8Z,11Z,14Z)); 110638
• Formule empirique (notation de Hill): C₄₁H₇₄NO₈P
• Numéro CAS: 70812-59-8
• Poids moléculaire : 740.00
• Code UNSPSC : 51191904
• Nomenclature NACRES : NA.25

Propriétés

• Pureté: >99% (TLC)
• Forme: powder
• Conditionnement: pkg of 1 × 2.5 mL (850759C-25mg)
• Fabricant/nom de marque: Avanti Research^™ - A Croda Brand 850759C
• Concentration: 10 mg/mL (850759C-25mg)
• Type de lipide: cardiolipins; phospholipids
• Conditions d'expédition: dry ice
• Température de stockage: −20°C
• Chaîne SMILES: [H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)COC(CCCCCCCCCCCCCCC)=O

Description

Application

16:0-20:4 PE has been used to determine its effect on oxidative burst in neutrophil granulocytes. It has also been used to determine its detergent solubility with equimolar concentration of sphingomyelin/cholesterol (SM/CHOL).

Conditionnement

5 mL Clear Glass Sealed Ampule (850759C-25mg)

Informations légales

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Informations sur la sécurité

• Pictogrammes: GHS06,GHS08
• Mention d'avertissement: Danger
• Mentions de danger: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• Conseils de prudence: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Classification des risques: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Organes cibles: Central nervous system, Liver,Kidney
• Code de la classe de stockage: 6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• Classe de danger pour l'eau (WGK): WGK 3
• Point d'éclair (°F): does not flash
• Point d'éclair (°C): does not flash